Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
156 participants
INTERVENTIONAL
2008-04-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Drug Use in Low Income Clinic Populations
NCT01942876
Medical Office Intervention for Adolescent Drug Use
NCT00229983
Martial Arts as Early Intervention for Teen Drug Abuse
NCT00956527
Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education
NCT00612482
Family and Social Intervention for Young People
NCT02399865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Art Messaging
4-session educational group which utilizes art, photography, film, painting to portray a message to reduce drug use, and prevent hepatitis A, B, \& C
Art Messaging
4-session educational group which utilizes art, photography, film, painting to portray a message to reduce drug use, and prevent hepatitis A, B, \& C
Health Promotion
4-session education offering basic information about the prevention of hepatitis A, B \& C
Health Promotion
4 session education which offers basic information about the prevention of hepatitis A, B, \& C
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Art Messaging
4-session educational group which utilizes art, photography, film, painting to portray a message to reduce drug use, and prevent hepatitis A, B, \& C
Health Promotion
4 session education which offers basic information about the prevention of hepatitis A, B, \& C
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. screened as a moderate-to-heavy drug user;
3. willing to be tested for HAV/HBV at baseline; and
4. not a participant of the Phase I study.
Exclusion Criteria
15 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adeline Nyamathi, MD
Distinguished Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Common Ground
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
081101501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.